April 29, 2017Current Opinion in Lipidology170 citations
View Full PaperAdiponectin, lipids and atherosclerosis
Key Points
Key points are not available for this paper at this time.
Abstract
Based on available data, adiponectin represents a multifaceted biomarker that may beneficially affect atherosclerosis, inflammation and insulin resistance pathways. However, there are conflicting results with regard to the associations between adiponectin levels and the prevalence and outcomes of cardiometabolic diseases. Further research on the potential clinical implications of adiponectin in the diagnosis and treatment of such diseases is needed.